All In Biotech

Free tool

Drug Search

Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.

Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations

10 matches for "Samsung Bioepis CO LTD"

Brand names that start with your search come first, then marketed and novel drugs.

DrugSponsorApplicationFirst approvedPrograms
Opuviz

Aflibercept-Yszy

Samsung Bioepis CO LTDBLA761350May 20, 2024
Byooviz

Ranibizumab-Nuna

Samsung Bioepis CO LTDBLA761202Sep 17, 2021
Epysqli

Eculizumab-Aagh

Samsung Bioepis CO LTDBLA761340Jul 19, 2024
Hadlima

Adalimumab-Bwwd

Samsung Bioepis CO LTDBLA761059Jul 23, 2019
Eticovo

Etanercept-Ykro

Samsung Bioepis CO LTDBLA761066Apr 25, 2019
Pyzchiva

Ustekinumab-Ttwe

Samsung Bioepis CO LTDBLA761373Jun 28, 2024
Pyzchiva

Ustekinumab-Ttwe

Samsung Bioepis CO LTDBLA761425Apr 30, 2025
Ontruzant

Trastuzumab-Dttb

Samsung Bioepis CO LTDBLA761100Jan 18, 2019
Renflexis

Infliximab-Abda

Samsung Bioepis CO LTDBLA761054Apr 21, 2017
Denosumab-Dssb

Denosumab-Dssb

Samsung Bioepis CO LTDBLA761392Oct 29, 2025

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.